Evidence map›Paper›PMID 38102591›Full record

ReviewBMC genomics2023

A comprehensive assessment of exome capture methods for RNA sequencing of formalin-fixed and paraffin-embedded samples.

Liang Zong, Yabing Zhu, Yuan Jiang, Ying Xia, Qun Liu, Sanjie Jiang

Abstract readReview
In one paragraph

Review in BMC genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liang Zong *Wuhan BGI Technology Service Co., Ltd. BGI-Wuhan, Wuhan, China.
Yabing Zhu *BGI Tech Solutions Co., Ltd. BGI-Shenzhen, Shenzhen, China.
Yuan JiangWuhan BGI Technology Service Co., Ltd. BGI-Wuhan, Wuhan, China.
Ying XiaWuhan BGI Technology Service Co., Ltd. BGI-Wuhan, Wuhan, China.
Qun LiuWuhan BGI Technology Service Co., Ltd. BGI-Wuhan, Wuhan, China.
Sanjie JiangBGI Tech Solutions Co., Ltd. BGI-Shenzhen, Shenzhen, China. jiangsanjie@bgi.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA-Seq analysis of Formalin-Fixed and Paraffin-Embedded (FFPE) samples has emerged as a highly effective approach and is increasingly being used in clinical research and drug development. However, the processing and storage of FFPE samples are known to cause extensive degradation of RNAs, which limits the discovery of gene expression or gene fusion-based biomarkers using RNA sequencing, particularly methods reliant on Poly(A) enrichment. Recently, researchers have developed an exome targeted RNA-Seq methodology that utilizes biotinylated oligonucleotide probes to enrich RNA transcripts of interest, which could overcome these limitations. Nevertheless, the standardization of this experimental framework, including probe designs, sample multiplexing, sequencing read length, and bioinformatic pipelines, remains an essential requirement. In this study, we conducted a comprehensive comparison of three main commercially available exome capture kits and evaluated key experimental parameters, to provide the overview of the advantages and limitations associated with the selection of library preparation protocols and sequencing platforms. The results provide valuable insights into the best practices for obtaining high-quality data from FFPE samples.

Indexed as

ExomeFormaldehydeGene Expression ProfilingParaffinParaffin EmbeddingRNASequence Analysis, RNATissue FixationFormaldehydeParaffinRNAFFPE samplesGene fusionRNA sequencing (RNA-Seq)

Identifiers

PMID38102591
PMCPMC10722801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.